MEMO 3D. The true reflection of the mitral annulus. Natural physiological 3D motion

Similar documents
ready to repair product brochure PERFORMANCE INNOVATION DESIGN mitral solutions

MEMO 3D RECHORD. Ready to repair. Guiding standards in Mitral valve repair

MEMO 4D Reshaping Mitral Repair

MITROFLOW VALSALVA CONDUIT TM

CROWN PRT. Inservice implantation guide

SOLO SMART. The smart way to return to life. Native-like performance now with stented-like implantability

REDUCING THE IMPACT OF SURGERY AND FACILITATING FASTER RECOVERY

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας

MICS & FEMORAL CANNULAE

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz

Surgical Repair of the Mitral Valve Presenter: Graham McCrystal Cardiothoracic Surgeon Christchurch Public Hospital

Despite advances in our understanding of the pathophysiology

Valve Analysis and Pathoanatomy: THE MITRAL VALVE

Posterior leaflet prolapse is the most common lesion seen

Echocardiographic Evaluation of Primary Mitral Regurgitation

THE FOLDING LEAFLET. Rafael García Fuster. Cardiac Surgery Department University General Hospital of Valencia

Percutaneous mitral valve repair/replacement. Jan Van der Heyden MD, PhD St.Antonius Hospital Nieuwegein

UNIRING, Universal Annuloplasty System Overview and Surgical Guidelines

Index. B B-type natriuretic peptide (BNP), 76

CONVENTIONAL ADULT CANNULAE

Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia.

Eva Maria Delmo Walter Takeshi Komoda Roland Hetzer

CONVENTIONAL ADULT CANNULAE

MitraClip in the ICCU: Which Patient will Benefit?

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC

Percutaneous Mitral Valve Repair

Surgical repair techniques for IMR: future percutaneous options?

PROVEN PLUS. Introducing the Avalus Aortic Valve by Medtronic.

The HRT Mitral Bridge Technology for Functional MR

The Versatile Polyaxial Solution for the Universal Spine Systems. USS II Polyaxial. Surgical Technique

Basic principles of Rheumatic mitral valve Repair

Percutaneous Valve Interventions. Percutaneous Valve Interventions

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Techniques for ischemic mitral valve disease: An Update. Stanford CV Surgery

Historical perspective R1 黃維立

The Edge-to-Edge Technique f For Barlow's Disease

Percutaneous Mitral Valve Repair

CROWN PRT. The crowning touch. Experience designs performance

Haiping Wang 1,2, Xiancheng Liu 2, Xin Wang 2, Zhenqian Lv 2, Xiaojun Liu 2, Ping Xu 1. Introduction

Surgical aortic valve replacement (AVR) is the established

Late secondary TR after left sided heart disease correction: is it predictibale and preventable

Cite this article as:

The Key Questions in Mitral Valve Interventions. Where Are We in 2018?

Steven F Bolling Professor of Cardiac Surgery University of Michigan

Quantitation of Mitral Valve Tenting in Ischemic Mitral Regurgitation by Transthoracic Real-Time Three-Dimensional Echocardiography

Annular Stabilization Techniques in the Context of Aortic Valve Repair

(Ann Thorac Surg 2008;85:845 53)

Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine

The Tricuspid Valve: The Not So Forgotten Valve. Manuel J Antunes Cardiothoracic Surgery Coimbra, Portugal

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?

Lifting posterior mitral annuloplasty for enhancing leaflet coaptation in mitral valve repair: midterm outcomes

8/31/2016. Mitraclip in Matthew Johnson, MD

Tricuspid leaflet repair: innovative solutions

Imaging to select patients for Transcatheter TV

Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical. The Houston Aortic Symposium February 23-25, 2017

Organic mitral regurgitation

Mitral Valve Disease, When to Intervene

NeoChord Mitral Valve Repair. Department of Cardiac, Thoracic and Vascular Sciences University of Padua, Italy

Functional Ischaemic Mitral Regurgitation: CABG + MV Replacement. Prakash P Punjabi. FRCS(Eng),FESC,MS,MCh,FCCP, Diplomate NBE

When should we intervene surgically in pediatric patient with MR?

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Imaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015

What echo measurements are key prior to MitraClip?

Use of MitraClip Beyond Everest Criteria

Σεμινάρια Ομάδων Εργασίας 2017 Ανεπάρκεια μιτροειδούς μυξωματώδους αιτιολογίας

Current status: Percutaneous mitral valve therapy

(12) Patent Application Publication (10) Pub. No.: US 2003/ A1

Percutaneous Mitral Valve Intervention: QuantumCor Device

The stentless bioprosthesis has many salient features that

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Atrioventricular valve repair: The limits of operability

The clinical problem of atrioventricular valve regurgitation

Part II: Fundamentals of 3D Echocardiography: Acquisition and Application

Transcatheter Echo Guided Mitral Valve Repair with NeoChord Implantation: Results from NeoChord Independent International Registry

Experience with 500 Stentless Aortic Valve Replacements

Mitral Valve Repair for Functional Mitral Regurgitation- Description of A New Technique and Classification System

I have financial relationships to disclose Honoraria from: Edwards

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

Prognostic Impact of FMR

Ischemic mitral regurgitation (IMR) is an insufficiency of

Ischemic Mitral Regurgitation

DEVELOPMENT OF A CRYO-ANCHORING AND RADIOFREQUENCY ABLATION CATHETER FOR PERCUTANEOUS TREATMENT OF MITRAL VALVE PROLAPSE. Steven Michael Boronyak

Transcatheter Mitral Valve Replacement How Close Are We?

Regional and Global Patterns of Annular Remodeling in Ischemic Mitral Regurgitation

Rigid, Complete Annuloplasty Rings Increase Anterior Mitral Leaflet Strains in the Normal Beating Ovine Heart

Indications and Late Results of Aortic Valve Repair

Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens

PATIENT BOOKLET MEDTRONIC MITRAL AND TRICUSPID HEART VALVE REPAIR

Mitral Programme Update

Anatomy of aortic valve and root Emmanuel Lansac MD PhD

Role of Sutureless Valves in the Surgeon s Armamentarium Prof. Dr Malakh Shrestha Vice Chair, Director of Aortic Surgery Cardiothoracic,

Three-dimensional echocardiography [1], sonomicrometry

Chordae replacement versus leaflet resection in minimally invasive mitral valve repair

Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan

Aortic valve repair: Techniques and Pitfalls. Allan Stewart, MD Columbia University Medical Center New York, NY

Functional Mitral Regurgitation

Finite Element Modeling of the Mitral Valve and Mitral Valve Repair

Repair or Replacement

Transcription:

MEMO 3D TM The true reflection of the mitral annulus Natural physiological 3D motion

Imagine... if there was one annuloplasty ring that provided an optimal solution across the entire spectrum of mitral valve repair. a single ring that could provide reproducible results, predictable outcomes, and superior performance. then imagine if that ring offered natural physiological 3D motion with an innovative internal cell structure, shape memory and a state of the art coating for enhanced hemo and biocompatibility to truly reflect the native mitral annulus. Stop imagining. 2

UNIQUE FEATURES MEMO 3D TM The Right Balance of Rigidity and Flexibility to Support any Repair Memo 3D TM semi-rigid annuloplasty ring is truly the only ring you ll ever need. Whether you re looking for stability to support annulus remodeling - or seek flexibility to allow natural motion of the annulus, the unique features of Memo 3D TM provide superior performance in both environments. 3D Innovative Nitinol Cell Structure The varying dimensions of the nitinol cell structure of Memo 3D TM allows for true physiological movement in all 3 dimensions. This helps to reduce stress on the repair by allowing the prosthesis to better accommodate the natural motion of the mitral annulus. The cell structure is optimized to provide a progressive degree of flexibility from the anterior to posterior portions of the ring. - Rigid - Flexible Carbofilm TM a LivaNova exclusive Coated entirely with Carbofilm TM, Memo 3D TM observed through TEE and MRI, has demonstrated its ability to preserve near phisiological ring motion after one year of implant 1,2. Recent clinical data showed this unique performance even after more than five years of implant 3. Carbofilm magnified to show texture Unique Saddle Shape Configuration The true physiological 3D motion of the ring during the cardiac cycle preserves the natural non-planar geometry saddle shape of the annulus. Recent clinical data have demonstrated that Memo 3D TM is able to accommodate the physiological saddle shape of the mitral annulus throughout the cardiac cycle upon implantation 7. MEMO 3D SADDLE SHAPING 4D MV assessment and Realview analysis: annular height changes during the cardiac cycle being highest in mid-systole and lowest in mid-diastole 7. 3

Saddle shape remodeling contributes to increased repair durability by redistributing leaflet stress and chordal tension 4,5,6. The LivaNova Memo 3D TM ring safely and effectively minimizes secondary MVR resulting from all causes and preserves mitral annular flexibility and function at follow-up 2. 4

MEMO 3D TM AN OPTIMAL SOLUTION ACROSS THE ENTIRE SPECTRUM OF VALVE REPAIR Shape Memory The Ni-Ti alloy core remembers a prefixed shape after geometric deformation and can be flexed back and forth without losing its original form. Memo 3D s shape memory provides consistent recovery of the systolic profile and restores the natural systolic diameter ratio. VERSATILITY Memo 3D has been successfully implanted in patients presenting a broad range of etiology classifications with applications in both degenerative and ischemic disease. BRUNO et al. 2 ETIOLOGY N % REIN et al. 8 ETIOLOGY N % 125 patients, mean age of 66 years, 79% NYHA Class III-IV, 14% NYHA Class I-II, 7% undefined Degenerative 69 55.2 Ischemic 19 15.2 Congenital 5 4.0 Rheumatic 8 6.4 Endocarditis 6 4.8 Barlow s Disease 5 4.0 Other 13 10.4 SORIN CLINICAL TRIAL 9 ETIOLOGY N % 63 patients, mean age 70 years, 76% NYHA Class III-IV, 24% NYHA Class I-II Degenerative 39 61.9 Ischemic 16 25.4 Barlow s Disease 4 6.4 Dilated Cardiomyopathy 4 6.4 228 patients, mean age 63 years, 39% NYHA Class III-IV, 61% % NYHA Class I-II Degenerative 172 75.4 Ischemic 42 18.5 Dilated Cardiomiopathy 11 25.0 Endocarditis 7 3.1 Rheumatic 7 3.1 EASE OF IMPLANT Ensuring a better fit The Memo 3D TM semirigid annuloplasty ring facilitates easier implantation with superior visualization, placement, and attachment. The oval cross section of the silicone sheath provides more material for easier needle penetration. White suture guidelines on the underside of Memo 3D TM provide an excellent visual reference point for easier suturing. White suture guideline to aid suture placement Oval silicone crosssection for easy needle penetration 5

NOW with improved HOLDER Compatible with new set of accessories designed also for MICS NEW HOLDER: Compatibility with new improved set of accessories, suitable also for MICS procedures Versatility of use: - one-step or two-step procedures for removal WARNING NOT TO BE USED WITH HANDLE RG-100 Use exclusively with the new ICV0664 Uni Handle or ICV1342 Extended Uni Handle for MICS NEW ACCESSORIES: Uni Handle Longer version of the universal bendable handle for MICS Improved ergonomic sizers Sizer heads with marked size for easy recognition Printed commissural markers to avoid annular suture entangling Extended Uni Handle Instrument Set Memo 3D TM Sizer Standard and MICS 6

Product ordering information MEMO 3D TM Memo 3D TM semirigid annuloplasty ring: Ni-Ti Alloy core covered by silicone and polyester fabric coated with Carbofilm TM Ordering Number Size A (mm) Orifice area (cm 2 ) ICV0966 24 24 2.30 ICV0967 26 26 2.78 ICV0968 28 28 3.28 ICV0969 30 30 3.78 ICV0970 ICV0971 32 34 32 34 4.39 4.98 A ICV0972 36 36 5.67 ICV0973 38 38 6.34 Accessories ordering information (not provided sterile) Catalog Number ICV0664 ICV1342 ICV1340 ICV1343 Name Uni Handle Extended Uni Handle Annuloplasty Ring Sizer Set Annuloplasty Ring Accessory Tray Description Universal Bendable Handle Universal Bendable Handle for MICS Complete Sizer Set (24 to 38 mm) Empty Instrument Tray References 1. Bargenda S. et al. Mitral valve repair with the new annuloplasty ring MEMO 3D flexibility one year after implantation. Sana Cardiac Surgical Clinic, Stuttgart, Germany. Society for Heart Valve Disease (abstract). Berlin. 2009. 2. Bruno et al. Early Clinical Experience and Echocardiographic Results with a New Semirigid Mitral Annuloplasty Ring: The Sorin Memo 3D. Ann Thorac Surg. 2009;88:1492-8. 3. Santarpino G. et al. First-in-man implantation of a Sorin MEMO 3D ring: Mitral annular flexibility is still preserved at 5 years of follow-up! Department of Cardiac Surgery, Klinikum Nürnberg, Nuremberg, Germany. (abstract). Int J Cardiol. 2012 Aug 23;159(2):e23-4. 4. Salgo IS. et al. Effect of Annular Shape on Leaflet Curvature in Reducing Mitral Leaflet Stress. Circulation. 2002;106:711-717. 5. Gorman JH. et al. Effect of regional ischemia on mitral valve annular saddle shape and function. Ann Thorac Surg. 2004;77:544-8. 6. Jimenez JH. et al. Effects of a saddle shaped annulus on mitral valve function and chordal force distribution: An in vitro Study. Annals of Biomedical Engineering. 2003;31:1171-1181. 7. Nishi H. et al. Real-time 3-dimensional transesophageal echocardiography enable the evaluation of annular dynamics of mitral valve repair. Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. Society of Heart Valve Disease (Abstract). Venice, 2013. 8. Rein et al. Sana Cardiac Surgical Clinic, Stuttgart, Germany. Institute Data, 2007. 9. Sorin Group. Multicentre Prospective Clinical Trial Interim Analysis. Internal Data. March 2011. 7

12/15 IC0870001419/J Manufactured by: Sorin Group Italia Srl A wholly-owned subsidiary of LivaNova Plc Via Crescentino - 13040 Saluggia (VC) Italy Теl: +39 0161 487472 - Fax: +39 0161 487316 info.cardiacsurgery@livanova.com Please always refer to the Instructions For Use (IFU) manual provided with each product for detailed information, warnings, precautions and possible adverse side effects. 2015 LivaNova all rights reserved.